The Procter & Gamble Earnings Conference Call - PROCTER & GAMBLE CO

Financial Performance:

• Organic sales grew 4.0% year-over-year, driven by volume (+2.4 pts), pricing (+0.4 pts), and mix (+1.0+ pts).
• Core earnings per share (EPS) reached $2.00, up $0.01 vs. prior year; currency-neutral core EPS was flat.
• Core growth margin declined 150 basis points; core operating margin declined 80 basis points due to commodity and freight costs.
• Pre-cash flow productivity was 93%, and global aggregate market share remained flat, though 29 of the top 50 category-country combinations held or grew share (up from 25).
• Total cash returned to shareholders was $3.9 billion ($2.6B dividends, $1.3B share repurchases).
• Combined input costs for exchange items below the operating line are expected to be a $1.9 billion after-tax headwind for the full fiscal year.

Guidance and Future Outlook:

• Fiscal 27 organic sales guidance maintained at 1% to 3%, with Q1 start above range but expected volatility due to base effects and consumer demand headwinds.
• Core EPS guidance maintained at $6.89 to $7.11 (0% to 3% growth), incorporating a $1.4 billion after-tax cost headwind from higher raw materials, energy, and freight (assuming $100/barrel oil).
• Cost headwinds expected to materially increase in Q2 and the second half due to sustained high oil prices, with additional FX and net interest expense impacts starting in Q2.
• Capital spending forecast at 4.5% to 5.5% of sales; free cash flow productivity targeted at 85% to 90% for the year.
• Outlook includes a $15 billion cash return plan ($10B+ dividends, ~$5B buybacks) and assumes no major supply chain disruptions or store closures within the range.

Business Segments and Product Lines:

• All 10 product categories posted organic sales growth; Fabric, Home, Baby, Hair, Skin/Personal Care, and Grooming grew mid-single digits; Family, Feminine, Oral, and Personal Health grew low-single digits.
• Geographic performance: Greater China +8% (driven by Pampers +~50% and SK-II +12%), Europe +4% (UK high-single-digit), North America +3%, Latin America +4%, and IMETA +8%.
• Key product successes include Pantene "Abundant & Strong" (mid-single digit growth in US), Pampers "Amore" (projected >$100M in year one), and Ferry Dish (double-digit growth in GCC via UGC campaign).
• The "Thorne" business is now included in the outlook following its acquisition in early October.

Market and Competitive Landscape:

• Global category value growth estimated at 2.5% to 3.0%, with the U.S. approaching 3.0% and enterprise markets growing 4-6%.
• Competitive intensity remains high, particularly in baby care in the U.S. and China, where P&G benefited from competitor supply disruptions.
• P&G aims to grow categories rather than solely taking share, leveraging innovation to expand the total market.
• Restructuring efforts are ongoing, with a target of having over 80% of top U.S. customers holding or growing share by year-end.

Risks and Challenges:

• Significant headwinds from volatile raw material prices, energy costs, and freight, exacerbated by geopolitical conflicts (Middle East) and currency fluctuations.
• Consumer affordability pressures persist due to high fuel and energy costs, particularly heading into fall/winter.
• Quarterly volatility is expected due to shipment timing, inventory shifts, and base year effects.
• Specific challenges remain in Family Care (not yet back to share growth) and Olay in China (under reinvention), alongside a slow cold/cough season affecting healthcare previously.

Management Commentary and Tone:

• Management expressed confidence in the acceleration of top-line results and the effectiveness of strategic interventions, noting a "strong start."
• Tone is optimistic regarding long-term transformation and category growth opportunities but cautious and realistic about short-term volatility and cost pressures.
• Emphasis placed on "pricing with innovation" and structural productivity gains to offset cost inflation.
• Leadership highlighted the success of their new execution framework in identifying and fixing "superiority gaps" across categories and countries.

Analyst Questions and Answers:

• Margins: CFO Scholten explained improved operating leverage is structural (automation, restructuring, brand building efficiency) but noted Q1 margins were partially inflated by a one-time IEPA tariff refund and partial commodity flow-through.
• Sustainability: Management expects ~3% organic growth in H1 with slight acceleration in H2, though quarter-to-quarter volatility is likely due to inventory and promotion timing.
• China Growth: Attributes strong China performance (8% organic) to structural changes post-pandemic, social-first marketing, and distributor network reinvention; competitive dynamics in baby care provided a temporary tailwind but core growth remains mid-single digits.
• P&G vs. Thorne: P&G will support Thorne's international expansion and supply chain capabilities but intends to let the Thorne team lead operations to maintain its unique culture.
• Cost Recovery: Pricing actions are planned to be timed with innovation cycles; productivity is expected to drive 250+ bps of margin improvement, though commodity impacts will be absorbed gradually.

Other Key Points:

• P&G is adopting a new reporting standard for sales growth to one decimal place.
• The IMETA region (India, Middle East, Turkey, Africa) is now a distinct growth cluster, replacing previous fragmented structures.
• Investor Day is scheduled for November 19 to detail the "CPG Company of the Future" transformation.
• The company is focusing on "user growth" and household penetration, particularly in emerging markets like India and the Middle East.
• Restructuring includes a 15% reduction in non-manufacturing headcount, with impacts beginning to flow through the P&L in the current fiscal year.